angiogenic cell precursors
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2006 (NCT00523224)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- angiogenic cell precursors
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02551679 | Phase 2 | Aug 1, 2014 | Hemostemix |
| NCT00523224 | Phase 1 | Jan 1, 2006 | Bangkok Heart Hospital, TheraVitae Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bangkok Heart Hospital | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Hemostemix | For profit | 1 | 1 | 1 | 2014 |
| TheraVitae Ltd. | For profit | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1